With Pfizer As Cornerstone Investor, Will Shanghai Pharmaceutical Be Largest Pharma IPO Ever?
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - Shanghai Pharmaceutical Holdings Co. Ltd is set for what could be the largest IPO by a pharmaceutical company ever, surpassing Ostuka Holding's $2.4 billion IPO from last year
You may also be interested in...
Shanghai Pharma Latest To Investigate Allegations Of Bribery In China
China’s second-largest pharmaceutical distributor Shanghai Pharmaceuticals is investigating allegations in a local paper that its subsidiary Qingdao Growful Pharmaceutical paid $126,200 in bribes between January and June to staff at 31 hospitals.
China’s Fosun Pharma Targets $650 Million IPO With Prudential Insurance As Cornerstone Investor
China’s largest non-state-owned pharma company Fosun Pharma commenced an initial global offering in Hong Kong, and nearly half of the money raised will be used for M&A. But the $650 million expected to be raised is much smaller than the rumored $800 million.
China’s Fosun Pharma Targets $650 Million IPO With Prudential Insurance As Cornerstone Investor
China’s largest non-state-owned pharma company Fosun Pharma commenced an initial global offering in Hong Kong, and nearly half of the money raised will be used for M&A. But the $650 million expected to be raised is much smaller than the rumored $800 million.